Device
CPAP device
CPAP device is a medical device with 4 clinical trials. Currently 1 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Completion Rate
0%(0/2)
Active Trials
1(25%)
Terminated
2(50%)
Phase Distribution
Ph not_applicable
3
75%
Ph phase_2
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 2 finished
Non-Completion Rate
100.0%
2 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Terminated(2)
Detailed Status
Terminated2
Recruiting1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
0.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (25.0%)
N/A3 (75.0%)
Trials by Status
recruiting125%
terminated250%
not_yet_recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
recruitingnot_applicable
Stroke and CPAP Outcome Study 3 Randomized Controlled Trial
NCT06722755
not_yet_recruitingnot_applicable
SMARTPHONE APPLICATION HOME-BASED EXERCISES IN OBSTRUCTIVE SLEEP APNEA IN JEDDAH
NCT06954974
terminatedphase_2
Systemic Inflammation and Obstructive Sleep Apnea Syndrome: Effect of Atorvastatin
NCT00669695
terminatednot_applicable
Oxidative Stress and Endothelial Dysfunction in Obstructive Sleep Apnea
NCT00646971
Clinical Trials (4)
Showing 4 of 4 trials
NCT06722755Not Applicable
Stroke and CPAP Outcome Study 3 Randomized Controlled Trial
NCT06954974Not Applicable
SMARTPHONE APPLICATION HOME-BASED EXERCISES IN OBSTRUCTIVE SLEEP APNEA IN JEDDAH
NCT00669695Phase 2
Systemic Inflammation and Obstructive Sleep Apnea Syndrome: Effect of Atorvastatin
NCT00646971Not Applicable
Oxidative Stress and Endothelial Dysfunction in Obstructive Sleep Apnea
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4